市場調查報告書
商品編碼
1006078

生技藥品的全球市場:各產品、各用途、各地區 - 市場規模、佔有率、預測,新型冠狀病毒感染疾病 (COVID-19)的影響 (2021年∼2027年)

Biologics Market with COVID-19 Impact Analysis, By Product, By Application, and By Region - Size, Share, & Forecast from 2021-2027

出版日期: | 出版商: AnalystView Market Insights | 英文 300 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球生技藥品的市場規模,2020年達到3306億美元,在預測期間內 (2021年∼2027年) 以9.8%的年複合成長率成長。預計各產品中的單株抗體,各用途中的癌症需求今後將大幅擴大。在各地區中北美市場和亞太地區市場預期今後迅速成長。

本報告提供全球生技藥品的市場相關分析,市場定義和基本結構,主要的推動及阻礙市場要素,產業的競爭力、向心力,市場佔有率結構,各產品、各用途、各地區的市場趨勢預測,主要企業的簡介,新型冠狀病毒感染疾病 (COVID-19)的影響等調查。

目錄

第1章 生技藥品市場概要

第2章 摘要整理

第3章 生技藥品市場:主要的市場趨勢

  • 推動市場要素
    • 推動市場要素的影響度分析
  • 阻礙市場要素
    • 阻礙市場要素的影響度分析
  • 市場機會
  • 未來市場趨勢

第4章 生技藥品市場:產業分析

  • 波特的五力分析
  • 行銷策略分析
  • 市場成長預測:製圖
  • 管理體制分析

第5章 生技藥品市場:新型冠狀病毒感染疾病 (COVID-19)的影響分析

  • "COVID-19前" 的影響分析
  • "COVID-19後" 的影響分析
    • 高業績市場區隔
    • 邊際成長市場區隔
    • 低業績市場區隔
    • 邊際損失市場區隔

第6章 生技藥品市場:市場環境

  • 市場佔有率分析 (2019年)
  • 主要的技術創新企業的分析
  • 市場區隔資料:各主要製造商
    • 現有企業分析
    • 新企業分析

第7章 生技藥品市場:各產品

  • 概要
  • 單株抗體
  • 疫苗
  • 重組荷爾蒙/蛋白質
  • 細胞為基礎的生技藥品
  • 遺傳基因為基礎的生技藥品
  • 其他

第8章 生技藥品市場:各用途

  • 概要
  • 自體免疫疾病
  • 癌症
  • 感染疾病
  • 罕見疾病
  • 其他

第9章 生技藥品市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區(APAC)
  • 南美
  • 中東、非洲

第10章 供應商分析

  • 競爭儀表板
  • 企業簡介
    • Unilife Corporation
    • Retractable Technologies, Inc.
    • Smiths Medicals
    • Becton, Dickinson & Company
    • Smiths Medical
    • Terumo Corporation
    • Pfizer Inc.
    • Roche Diagnostics
    • AstraZeneca
    • Bayer AG
    • Genzyme
    • GSK Biologicals
    • Lundbeck
    • Novartis AG
    • Merck KGaA
    • Janssen Pharmaceuticals, Inc.

第11章 分析師的全方位分析

第12章 附錄

目錄

REPORT HIGHLIGHT

The global biologics market was valued at USD 330.6 billion by 2020, growing with 9.8% CAGR during the forecast period, 2021-2027.

Biologics are medicines that are made up of genetically modified proteins derived from human genes. It could also be made up of proteins, sugars, nucleic acids, or complex combinations of these compounds, or living organisms like tissues and cells, according to the US FDA. The majority of biologics are complex mixtures that are prone to microbial contamination, heat-sensitive, difficult to classify or identify. Increasing government healthcare initiatives, rising availability of advanced diagnostics, and growing technological advances in research and development by major drug companies around the world to maintain competitiveness and investment in incremental innovation would drive biologics market growth during the forecast era.

Rising cancer diseases amongst the people have boosted the need for biologics. Biologic drugs have the ability to stimulate the body and spot cancer cells and attack them. According to the International Agency for Research on Cancer (IARC), 17.0 Mn new cancer cases and 9.5 Mn cancer deaths occurred globally in 2018. Simply due to population growth and aging, the global burden of cancer is projected to rise to 27.5 Mn new cases and 16.3 Mn cancer deaths by 2040. In economically transitioning nations, the potential burden would almost certainly be greater due to a rise in the prevalence of risk factors such as poor diet, smoking, fewer childbirths, and physical inactivity. Hence, such factors will lead to increasing the adoption of biologics drugs for the treatment of cancer. Furthermore, increasing technological advancement and research & development activities will also promote market growth. However, high complex nature of biologics causes difficulties in manufacturing. Hence, this acts as a restrain for the biologics market growth.

Based on the product analysis, the biologics market is categorized into monoclonal antibodies, vaccines, recombinant hormones/proteins, cellular-based biologics, and gene-based biologics. The monoclonal antibodies segment is anticipated to witness the highest growth during the forecast timeline. The growth is associated with the treatment of autoimmune diseases including rheumatoid arthritis and cancer management. The rising spread of contagious disease coupled with the increasing advancement of drugs will propel the vaccine segment growth. Based on application, the cancer segment holds the highest market share, due to the growing prevalence of cancer across the globe. Furthermore, an increasing product advancement will also contribute to boosting the demand for biologics during the forecasted era.

In the global market, North America accounted to witness the highest growth during the forecast period. The greater revenue share can be attributed to a higher demand for disease-treatment drugs. Furthermore, pharmaceutical firms in the United States are responsible for the highest market share of global R&D in healthcare biotechnology.

Due to the rising prevalence of diabetes in the Asia Pacific, this region is projected to be the fastest-growing region in the global biologics market. According to the International Diabetes Federation (IDF) Diabetes Atlas 2017, the number of people with diabetes aged 20 to 79 years in the Western Pacific regions and South East Asia in 2017 was 159 million and 82 million, respectively, according to the International Diabetes Federation (IDF). The increase in the aging population, changing lifestyles, and shifting purchasing habits on healthcare goods have all contributed to the biologics market expansion in Europe. The Middle East & Africa is anticipated to grow with sustainable growth owing to the rising adoption of recombinant protein in various applications.

Key features of the study:

This proposed research study on biologics market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2020-2027), considering 2019 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for biologics market

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the biologics market

Impact of COVID-19 on biologics market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on biologics market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the biologics market, we have also included competitive landscape and key innovator analysis for the biologics market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and end-user's attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the biologics market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new application launch, research & development, regional expansion of major participants involved in the biologics market on global as well as regional level.

The global biologics market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOLOGICS MARKET KEY PLAYERS

Unilife Corporation

Retractable Technologies, Inc.

Smiths Medicals

Becton, Dickinson & Company

Smiths Medical

Terumo Corporation

Pfizer Inc.

Roche Diagnostics

AstraZeneca

Bayer AG

Genzyme

GSK Biologicals

Lundbeck

Novartis AG

Merck KGaA

Janssen Pharmaceuticals, Inc.

GLOBAL BIOLOGICS MARKET, BY PRODUCT

Monoclonal Antibodies

Vaccines

Recombinant Hormones/Proteins

Cellular-based Biologics

Gene-based Biologics

Other

GLOBAL BIOLOGICS MARKET, BY APPLICATION

Autoimmune Diseases

Cancer

Infectious Diseases

Rare Diseases

Others

GLOBAL BIOLOGICS MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. Biologics Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Product
    • 2.1.2. Market Snippet by Application
    • 2.1.3. Market Snippet by Region
  • 2.2. Competitive Insights

3. Biologics Key Market Trends

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. Biologics Industry Study

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biologics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Biologics Market Landscape

  • 6.1. Market Share Analysis, 2019
  • 6.2. Key Innovators Analysis
  • 6.3. Breakdown Data, by Key Manufacturer
    • 6.3.1. Established Players' Analysis
    • 6.3.2. Emerging Players' Analysis

7. Biologics Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2020 & 2027 (%)
  • 7.2. Monoclonal Antibodies
  • 7.3. Vaccines
  • 7.4. Recombinant Hormones/Proteins
  • 7.5. Cellular-based Biologics
  • 7.6. Gene-based Biologics
  • 7.7. Other

8. Biologics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2020 & 2027 (%)
  • 8.2. Autoimmune Diseases
  • 8.3. Cancer
  • 8.4. Infectious Diseases
  • 8.5. Rare Diseases
  • 8.6. Others

9. Biologics Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 9.3.10. Rest of Europe
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.10.3. Rest of Europe Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 9.3.10.4. Rest of Europe Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
    • 9.4.10. Rest of APAC
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.10.3. Rest of APAC Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 9.4.10.4. Rest of APAC Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 9.5.9. Rest of LATAM
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.5.9.3. Rest of LATAM Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 9.5.9.4. Rest of LATAM Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)

10. Key Vendor Analysis

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Unilife Corporation
    • 10.2.2. Retractable Technologies, Inc.
    • 10.2.3. Smiths Medicals
    • 10.2.4. Becton, Dickinson & Company
    • 10.2.5. Smiths Medical
    • 10.2.6. Terumo Corporation
    • 10.2.7. Pfizer Inc.
    • 10.2.8. Roche Diagnostics
    • 10.2.9. AstraZeneca
    • 10.2.10. Bayer AG
    • 10.2.11. Genzyme
    • 10.2.12. GSK Biologicals
    • 10.2.13. Lundbeck
    • 10.2.14. Novartis AG
    • 10.2.15. Merck KGaA
    • 10.2.16. Janssen Pharmaceuticals, Inc.

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Biologics market: Product Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Biologics market, by Product 2016-2027 (USD Million)
  • TABLE Biologics market: Application Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Biologics market, by Application 2016-2027 (USD Million)
  • TABLE Biologics market: Regional snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Biologics market, by Region 2016-2027 (USD Million)
  • TABLE North America Biologics market, by Country, 2016-2027 (USD Million)
  • TABLE North America Biologics market, by Product, 2016-2027 (USD Million)
  • TABLE North America Biologics market, by Application, 2016-2027 (USD Million)
  • TABLE Europe Biologics market, by Country, 2016-2027 (USD Million)
  • TABLE Europe Biologics market, by Product, 2016-2027 (USD Million)
  • TABLE Europe Biologics market, by Application, 2016-2027 (USD Million)
  • TABLE Asia Pacific Biologics market, by Country, 2016-2027 (USD Million)
  • TABLE Asia Pacific Biologics market, by Product, 2016-2027 (USD Million)
  • TABLE Asia Pacific Biologics market, by Application, 2016-2027 (USD Million)
  • TABLE Latin America Biologics market, by Country, 2016-2027 (USD Million)
  • TABLE Latin America Interface Devices market, by Product, 2016-2027 (USD Million)
  • TABLE Latin America Biologics market, by Application, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Biologics market, by Country, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Biologics market, by Product, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Biologics market, by Application, 2016-2027 (USD Million)

List of Figures

  • FIGURE Biologics market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2019
  • FIGURE Product segment market share analysis, 2020 & 2027
  • FIGURE Product segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Application segment market share analysis, 2020 & 2027
  • FIGURE Application segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Regional segment market share analysis, 2020 & 2027
  • FIGURE Regional segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE North America Biologics market share and leading players, 2019
  • FIGURE Europe Biologics market share and leading players, 2019
  • FIGURE Asia Pacific Biologics market share and leading players, 2019
  • FIGURE Latin America Biologics market share and leading players, 2019
  • FIGURE Middle East and Africa Biologics market share and leading players, 2019
  • FIGURE North America market share analysis by country, 2019
  • FIGURE U.S. Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Canada Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Europe Biologics market share analysis by country, 2019
  • FIGURE Germany Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Spain Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Italy Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE UK Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE France Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of the Europe Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Asia Pacific Biologics market share analysis by country, 2019
  • FIGURE India Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE China Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Japan Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE South Korea Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Singapore Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of APAC Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Biologics market share analysis by country, 2019
  • FIGURE Brazil Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Mexico Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Argentina Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of LATAM Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Biologics market share analysis by country, 2019
  • FIGURE Saudi Arabia Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE United Arab Emirates Biologics market size, forecast and trend analysis, 2016 to 2027 (USD Million)